Skip to content

Vaginal Progesterone Supplementation in the Management of Preterm Labor

Vaginal Progesterone Supplementation in the Management of Preterm Labor: A Randomized, Double Blind, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03202836
Enrollment
90
Registered
2017-06-29
Start date
2017-06-29
Completion date
2018-07-31
Last updated
2019-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Labor

Brief summary

This study evaluates the addition of vaginal progesterone in the management of preterm labor. Half of participants will receive vaginal progesterone, tocolysis and corticosteroid, while the other half will receive only tocolysis and corticosteroid.

Interventions

DRUGprogesterone

vaginal utrogestan

DRUGTocolytics

tocolysis for 48 hours

DRUGSteroids

antenatal corticosteroids for 48 hours

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* singleton pregnant women with preterm labor, gestational age 24-34 weeks

Exclusion criteria

* have indicated preterm birth * allergy to progesterone * fetal anomalies * cervical dilate \> 5 cm. * have medical disease * have obstetric complication

Design outcomes

Primary

MeasureTime frameDescription
Time from preterm labor pain to delivery9 weekstime since preterm labor to delivery

Secondary

MeasureTime frameDescription
number of pregnant women deliver before 34 weeks6 weekspreterm birth \< 34 weeks
number of pregnant women deliver before 37 weeks9 weekspreterm birth \< 37 weeks
Number of newborn with respiratory distress syndrome9 weeksNumber of newborn with respiratory distress syndrome
gestational age at delivery9 weeksgestational age at birth
Number of newborn with necrotizing enterocolitis9 weeksNumber of newborn with necrotizing enterocolitis
Number of newborn with sepsis9 weeksNumber of newborn with sepsis
Number of newborn with intraventricular hemorrhage9 weeksNumber of newborn with intraventricular hemorrhage

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026